TDO2 and neoplasm: Mechanistically, TDO2 upregulates interleukin-8 (IL-8), activating the protein kinase B (AKT)/ glycogen synthase kinase-3 (GSK3β) pathway and promoting M2 macrophage polarization, thereby accelerating tumor progression in EC [37].